Author response for 'Combination Therapy with Pioglitazone/Exenatide Improves Beta Cell Function and Produces Superior Glycemic Control Compared to Basal/Bolus Insulin in Poorly Controlled T2DM : 3‐Year Follow‐up of the Qatar Study'

Autor:	Ebaa Al‐Ozairi, Osama Migahid, Ayman Megahed, Amin Jayyousi, Muhammad A. Abdul-Ghani, Ralph A. DeFronzo
Rok vydání:	2020
Předmět:	Basal bolus insulin Combination therapy business.industry medicine Beta-cell Function Pharmacology business Pioglitazone Exenatide medicine.drug Glycemic
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d6e3f3a29cdbd55b62f7c79de5ab588d https://doi.org/10.1111/dom.14153/v2/response1 Zobrazit plný text záznamu